LL37

LL37 5mg × 10 Vials – Comprehensive Research Overview for 2025

LL37, a naturally occurring antimicrobial peptide derived from the human immune system, has become a central focus in modern laboratory and biomedical research. The specification LL37 5mg × 10 vials refers to a research package containing ten sterile vials, each with 5 milligrams of high-purity LL37 peptide in lyophilized form. This format is ideal for controlled experimental applications in microbiology, immunology, tissue regeneration, wound research, and cellular studies.

What Is LL37 Peptide?

LL37 is a cationic antimicrobial peptide belonging to the cathelicidin family, naturally produced by human epithelial tissues and immune cells. Its structure enables it to bind to microbial membranes, making it a valuable subject for research into antibacterial, antiviral, and antifungal defense mechanisms. The LL37 5mg × 10 vials format provides researchers with standardized, high-quality material suitable for repeated experimentation across various controlled studies.

Key Research Applications of LL37

1. Antimicrobial and Antibiofilm Studies

LL37 demonstrates strong antimicrobial activity in vitro, making it a critical peptide for studying bacterial membrane interactions, biofilm inhibition, and mechanisms of innate immunity. Researchers often evaluate its potential role in addressing resistant microorganisms and wound-site bacterial colonization.

2. Immunomodulation Research

Beyond antimicrobial effects, LL37 is known for its role in modulating immune responses. Studies focus on analyzing inflammatory pathways, cytokine interactions, and LL37’s involvement in enhancing immune cell signaling during infection or tissue damage.

3. Tissue Regeneration and Wound Biology

LL37 plays an important role in epithelial repair, angiogenesis, and cell proliferation. The peptide is frequently used in experimental research exploring wound healing, regenerative medicine, and scar formation to understand how LL37 influences recovery processes at the cellular level.

4. Viral Defense Mechanisms

Laboratories also investigate LL37 for its ability to disrupt viral envelopes and influence antiviral immunity. These studies contribute to a deeper understanding of LL37’s potential role in natural defense processes against various viral pathogens.

Benefits of Using LL37 5mg × 10 Vials in Research

Consistent Dosing and Accuracy

Each vial contains 5mg of LL37, allowing precise measurement and consistent results across multiple experiments. Researchers appreciate the convenience of standardized quantities for accurate data collection.

Controlled Laboratory Packaging

The 10-vial set provides flexibility for long-term projects, enabling researchers to use one vial per experiment and maintain controlled conditions for each study stage.

Handling, Storage, and Reconstitution

Proper handling ensures structural integrity and reliable performance in scientific procedures. Gentle swirling (not shaking) helps maintain peptide structure.

Quality and Purity Standards

Certificates of Analysis (COA) typically accompany each batch to verify identity, purity, and safety for laboratory use. High-purity LL37 ensures reproducible experimental results and consistency across multiple study phases.

Safety and Compliance Advisory

LL37 is strictly a research-only peptide. Conclusion The LL37 5mg × 10 vials configuration offers researchers exceptional convenience, precision, and quality for a wide range of scientific explorations involving antimicrobial activity, immune modulation, tissue repair, and cellular defense mechanisms. With its growing relevance in biological and biomedical research, LL37 continues to be a valuable tool for laboratories seeking insights into natural immunity and advanced molecular processes. Proper handling, storage, and adherence to research standards ensure accurate, repeatable, and high-quality experimental results that contribute to ongoing scientific advancements.